Cargando…
Laninamivir octanoate for post-exposure prophylaxis of influenza in household contacts: a randomized double blind placebo controlled trial
Laninamivir octanoate, a long-acting neuraminidase inhibitor, is an effective treatment for influenza. However, its effectiveness for the prevention of influenza has not yet been demonstrated. We conducted a double-blind, multicenter, randomized, placebo-controlled trial to determine whether laninam...
Autores principales: | Kashiwagi, Seizaburo, Watanabe, Akira, Ikematsu, Hideyuki, Awamura, Shinichiro, Okamoto, Takako, Uemori, Mitsutoshi, Ishida, Katsuyasu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738841/ https://www.ncbi.nlm.nih.gov/pubmed/23732307 http://dx.doi.org/10.1007/s10156-013-0622-9 |
Ejemplares similares
-
Long-acting Neuraminidase Inhibitor Laninamivir Octanoate as Post-exposure Prophylaxis for Influenza
por: Kashiwagi, Seizaburo, et al.
Publicado: (2016) -
Immune-mediated Drug-induced Liver Injury Caused by Laninamivir Octanoate Hydrate
por: Kawaguchi, Toshihiro, et al.
Publicado: (2019) -
Structural and Functional Analysis of Laninamivir and its Octanoate Prodrug Reveals Group Specific Mechanisms for Influenza NA Inhibition
por: Vavricka, Christopher J., et al.
Publicado: (2011) -
Comparison of the clinical effectiveness of zanamivir and laninamivir octanoate for children with influenza A(H3N2) and B in the 2011–2012 season
por: Koseki, Naoko, et al.
Publicado: (2014) -
Impact of the number of repeated inhalations and patient characteristics on the residual amount of inhaled laninamivir octanoate hydrate dry powder in pediatric patients with influenza
por: Murasaka, Toshiki, et al.
Publicado: (2017)